The FY 2012 request for NIA is $1,129.987 million, an increase of $20.351 million or +1.8 percent over the FY 2010 level.
Of the funds requested, a net increase of $5.329 million is requested to bolster NIA support for investigator-initiated competitive research projects.
Funds are included in R&D contracts to reflect NIA’s share of NIH-wide funding required to support several trans-NIH initiatives, such as the Therapeutics for Rare and Neglected Diseases program (TRND), the Basic Behavioral and Social Sciences Opportunity Network (OppNet), and support for a new synchrotron at the Brookhaven National Laboratory. For example, each IC that will benefit from the new synchrotron will provide funding to total NIH’s commitment to support this new technology -- $10 million.
NIH will provide an across-the-board increase in FY 2012 of four percent for stipends levels under the Ruth L. Kirschstein National Research Service Award training program to continue efforts to attain the stipend levels recommended by the National Academy of Sciences. This will build on the two percent increase in stipend levels for FY 2011. Stipend levels were largely flat for several years, and the requested increase will help to sustain the development of a highly qualified biomedical research workforce.